T1 vs. T2 weighted magnetic resonance imaging to assess total kidney volume in patients with autosomal dominant polycystic kidney disease

Clinical Correlates of Mass Effect in Autosomal Dominant Polycystic Kidney Disease

(2015) Hyunsuk Kim et al.   PLoS One

Imaging Classification of Autosomal Dominant Polycystic Kidney Disease: A Simple Model for Selecting Patients for Clinical Trials

(2014) M. V. Irazabal et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Rationale and Design of the DIPAK 1 Study: A Randomized Controlled Clinical Trial Assessing the Efficacy of Lanreotide to Halt Disease Progression in Autosomal Dominant Polycystic Kidney Disease

(2013) Esther Meijer et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Epidemiology of autosomal-dominant polycystic kidney disease: an in-depth clinical study for south-western Germany

(2013) Hartmut P.H. Neumann et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Kidney Volume and Functional Outcomes in Autosomal Dominant Polycystic Kidney Disease

(2012) A. B. Chapman et al.   Clinical Journal of the American Society of Nephrology

Use of Antihypertensive Medications and Mortality of Patients With Autosomal Dominant Polycystic Kidney Disease: A Population-Based Study

(2011) Christine Patch et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Imaging for the prognosis of autosomal dominant polycystic kidney disease

(2010) Kyongtae T. Bae et al.   Nature Reviews Nephrology

MRI-based Kidney Volume Measurements in ADPKD: Reliability and Effect of Gadolinium Enhancement

(2009) K. T. Bae et al.   Clinical Journal of the American Society of Nephrology

Current Status of Gadolinium Toxicity in Patients with Kidney Disease

(2009) M. A. Perazella   Clinical Journal of the American Society of Nephrology

Unified Criteria for Ultrasonographic Diagnosis of ADPKD

(2008) Y. Pei et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY